A detailed history of Pinpoint Asset Management LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Pinpoint Asset Management LTD holds 50,974 shares of AZN stock, worth $3.38 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
50,974
Holding current value
$3.38 Million
% of portfolio
1.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $3.91 Million - $4.47 Million
50,974 New
50,974 $3.97 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $181,579 - $200,760
2,800 Added 20.9%
16,200 $1.1 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $936,794 - $1.02 Million
13,400 New
13,400 $959,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Pinpoint Asset Management LTD Portfolio

Follow Pinpoint Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinpoint Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinpoint Asset Management LTD with notifications on news.